1. Calderón-Larrañaga, A. et al. Multimorbidity, polypharmacy, referrals, and adverse drug events: are we doing things well? Br J Gen Pract. 2012; 62: e821–e826.
2. Green, J. L., Hawley, J. N. & Rask, K. J. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother. 2007; 5: 31–39.
3. Suzuki, T., Iwagami, M., Hamada, S., Matsuda, T. & Tamiya, N. Number of consulting medical institutions and risk of polypharmacy in community-dwelling older people under a healthcare system with free access: a cross-sectional study in Japan. BMC Health Services Research. 2020; 20: 359.
4. Kalisch, L. M., Caughey, G. E., Roughead, E. E. & Gilbert, A. L. The prescribing cascade. Aust Prescr. 2011; 34: 162–166.
5. Turnheim, K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol. 2003; 38: 843–853.
6. Doan, J., Zakrzewski-Jakubiak, H., Roy, J., Turgeon, J. & Tannenbaum, C. Prevalence and risk of potential cytochrome P450-mediated drug-drug interactions in older hospitalized patients with polypharmacy. Ann Pharmacother. 2013; 47: 324–332.
7. Pasina, L. et al. Medication non-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014; 31: 283–289.
8. Maher, R. L., Hanlon, J. T. & Hajjar, E. R. Clinical Consequences of Polypharmacy in Elderly. Expert Opin Drug Saf. 2014; 13: 10.1517/14740338.2013.827660.
9. Kojima, T. et al. High risk of adverse drug reactions in elderly patients taking six or more drugs: Analysis of inpatient database. Geriatrics & Gerontology International. 2012; 12: 761–762.
10. Kojima, T. et al. Polypharmacy as a risk for fall occurrence in geriatric outpatients. Geriatrics & Gerontology International. 2012; 12: 425–430.
11. Martin, N. J., Stones, M. J., Young, J. E. & Bédard, M. Development of delirium: a prospective cohort study in a community hospital. Int Psychogeriatr. 2000; 12: 117–127.
12. Fried, T. R. et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014; 62: 2261–2272.
13. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019; 67: 674–694.
14. Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A. & Busto, U. E. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ. 2005; 331: 1169.
15. Manias, E., Kabir, M. Z. & Maier, A. B. Inappropriate medications and physical function: a systematic review. Ther Adv Drug Saf. 2021; 12: 20420986211030372.
16. Fick, D. M., Mion, L. C., Beers, M. H. & Waller, J. L. Health Outcomes Associated With Potentially Inappropriate Medication Use in Older Adults. Res Nurs Health. 2008; 31: 42–51.
17. Wakabayashi, H. Rehabilitation pharmacotherapy: A combination of rehabilitation and pharmacotherapy. J Gen Fam Med. 2018; 19, 43–44.
18. Kose, E. et al. The relationship between polypharmacy and recovery of activities of daily living among convalescent stroke patients: A propensity score-matched analysis. European Geriatric Medicine. 2017; 8: 250–255.
19. Kose, E., Hirai, T. & Seki, T. Clinical factors affecting potentially inappropriate medications at discharge in older stroke patients. Eur Geriatr Med. 2018; 9: 161–168.
20. Shigematsu, K., Nakano, H. & Watanabe, Y. The eye response test alone is sufficient to predict stroke outcome--reintroduction of Japan Coma Scale: a cohort study. BMJ Open. 2013; 3: e002736.
21. Rubenstein, L. Z., Harker, J. O., Salvà, A., Guigoz, Y. & Vellas, B. Screening for undernutrition in geriatric practice: developing the short-form mini-nutritional assessment (MNA-SF). J Gerontol A Biol Sci Med Sci. 2001; 56: M366-372.
22. Kunieda, K., Ohno, T., Fujishima, I., Hojo, K. & Morita, T. Reliability and validity of a tool to measure the severity of dysphagia: the Food Intake LEVEL Scale. J Pain Symptom Manage. 2013; 46: 201–206.
23. Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373–383.
24. Banks, J. L. & Marotta, C. A. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007; 38: 1091–1096.
25. Ottenbacher, K. J., Hsu, Y., Granger, C. V. & Fiedler, R. C. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil. 1996; 77: 1226–1232.
26. Kaido, T. & Uemoto, S. Direct segmental multi-frequency bioelectrical impedance analysis is useful to evaluate sarcopenia. Am J Transplant. 2013; 13: 2506–2507.
27. Chen, L.-K. et al. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020; 21: 300-307.e2.
28. By the 2019 American Geriatrics Society Beers Criteria® Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults: 2019 AGS BEERS CRITERIA® UPDATE EXPERT PANEL. J Am Geriatr Soc. 2019; 67: 674–694.
29. Kus, S., Müller, M., Strobl, R. & Grill, E. Patient goals in post-acute geriatric rehabilitation--goal attainment is an indicator for improved functioning. J Rehabil Med. 2011; 43: 156–161.
30. Kido, Y. et al. Sarcopenia is associated with incontinence and recovery of independence in urination and defecation in post-acute rehabilitation patients. Nutrition. 2021; 91–92: 111397.
31. Beninato, M. et al. Determination of the minimal clinically important difference in the FIM instrument in patients with stroke. Arch Phys Med Rehabil. 2006; 87: 32–39.
32. Nishioka, S. et al. Clinical practice guidelines for rehabilitation nutrition in cerebrovascular disease, hip fracture, cancer, and acute illness: 2020 update. Clinical Nutrition ESPEN. 2021; 43: 90–103.
33. Oyanagi, K. et al. Effect of early intensive rehabilitation on the clinical outcomes of patients with acute stroke. Geriatr Gerontol Int. 2021; 21: 623–628.
34. Yoshimura, Y. et al. Shorter Interval between Onset and Admission to Convalescent Rehabilitation Wards Is Associated with Improved Outcomes in Ischemic Stroke Patients. Tohoku J Exp Med. 2020; 252: 15–22.
35. Yoshimura, Y. et al. Systemic Inflammation in the Recovery Stage of Stroke: Its Association with Sarcopenia and Poor Functional Rehabilitation Outcomes. Prog Rehabil Med. 2018; 3: 20180011.
36. Shimazu, S. et al. Frequent and personalized nutritional support leads to improved nutritional status, activities of daily living, and dysphagia after stroke. Nutrition. 2021; 83: 111091.
37. Kose, E., Hirai, T., Seki, T. & Hayashi, H. The association of increased drugs use with activities of daily living and discharge outcome among elderly stroke patients. Int J Clin Pharm. 2018; 40: 599–607.
38. Heuberger, R. A. & Caudell, K. Polypharmacy and Nutritional Status in Older Adults. Drugs Aging. 2011; 28: 315–323.
39. Kose, E., Hirai, T., Seki, T. & Hayashi, H. Role of potentially inappropriate medication use in rehabilitation outcomes for geriatric patients after strokes. Geriatrics & Gerontology International. 2018; 18: 321–328.
40. Vluggen, T. P. M. M. et al. Factors associated with successful home discharge after inpatient rehabilitation in frail older stroke patients. BMC Geriatr. 2020; 20: 25.
41. Chang, F.-H., Ni, P. & Jette, A. M. Does activity limitation predict discharge destination for postacute care patients? Am J Phys Med Rehabil. 2014; 93: 782–790.
42. Everink, I. H. J., van Haastregt, J. C. M., van Hoof, S. J. M., Schols, J. M. G. A. & Kempen, G. I. J. M. Factors influencing home discharge after inpatient rehabilitation of older patients: a systematic review. BMC Geriatr. 2016; 16: 5.
43. Yoshimura, Y. et al. Sarcopenia is associated with worse recovery of physical function and dysphagia and a lower rate of home discharge in Japanese hospitalized adults undergoing convalescent rehabilitation. Nutrition. 2019; 61: 111–118.
44. Kose, E., Hirai, T. & Seki, T. Psychotropic drug use and cognitive rehabilitation practice for elderly patients. Int J Clin Pharm. 2018; 40: 1292–1299.
45. Gamble, J.-M. et al. Medication transitions and polypharmacy in older adults following acute care. Ther Clin Risk Manag. 2014; 10: 189–196.
46. Mixon, A. S., Neal, E., Bell, S., Powers, J. S. & Kripalani, S. Care transitions: a leverage point for safe and effective medication use in older adults--a mini-review. Gerontology. 2015: 61: 32–40.
47. Clarke, C. L. & Witham, M. D. The Effects of Medication on Activity and Rehabilitation of Older People – Opportunities and Risks. Rehabilitation Process and Outcome. 2017; 6: 1179572717711433.
48. O’Mahony, D. et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age and Ageing. 2015; 44: 213–218.